Immunic (NasdaqGS:IMUX) 2026 R&D Day September 09, 2026 11:00 AM ET Company ParticipantsJessica Breu - VP of Investor Relations and CommunicationsErik Lundgren - CEOAmit Bar-Or - Melissa and Paul Anderson President's Distinguished Professor of NeurologyHella Kohlhof - Co-Founder and Chief Scientific OfficerMike Panzara - CMOStephen Krieger - Professor of NeurologyJason Tardio - President and COOConference Call ParticipantsMyles Minter - AnalystYatin Suneja - AnalystMarc Goodman - AnalystJessica Breuas devel ...

Relapsing Multiple Sclerosis R&D Day September 9, 2026 Virtual NASDAQ: IMUX © Immunic, Inc. | Sep 2026 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains "forward-looking statements" that involve substantial risks and uncertainties for purposes of the safe harbor within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements regarding management's intentions, plans, belie ...